Balu, Deebika
Valencia-Olvera, Ana C.
Nguyen, Austin
Patnam, Mehul
York, Jason
Peri, Francesco
Neumann, Frank
LaDu, Mary Jo
Tai, Leon M.
Funding for this research was provided by:
National Institutes of Health (R01 AG057008, R01 AG058068, R01 AG057008, R21 AG044682-01, R21 AG044682-01, R01AG061114)
College of Medicine, University of Illinois at Chicago (Institutional funds, Institutional funds, Institutional funds, Institutional funds, Institutional funds)
Louis and Christine Friedrich (Philanthropic support, Philanthropic support, Philanthropic support, Philanthropic support, Philanthropic support)
Article History
Received: 10 March 2023
Accepted: 10 October 2023
First Online: 19 October 2023
Declarations
:
: All experiments follow the University of Illinois at Chicago Animal Care and Use Committee protocols.
: Not applicable.
: FN is the founder and owner of the privately held company Innaxon Biosciences. No other competing interests.